Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumorsGeorge Mellgard, Che‐Kai Tsao, Mahalya Gogerly-Moragoda et al.|Journal of Cancer Research and Clinical Oncology|2022Cited by 23
Type, timing, and patient characteristics associated with immune-related adverse event development in patients with advanced solid tumors treated with immune checkpoint inhibitors.Qian Qin, Che‐Kai Tsao, Vaibhav G. Patel et al.|Journal of Clinical Oncology|2020Cited by 16
Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysisQian Qin, Che‐Kai Tsao, Tomi Jun et al.|Discover Oncology|2022Cited by 12
Smoking status and immunotherapy outcomes in smoking-associated cancers.Tomi Jun, Che‐Kai Tsao, Teja Ganta et al.|Journal of Clinical Oncology|2020Cited by 3
Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors.Vaibhav G. Patel, Che‐Kai Tsao, Qian Qin et al.|Journal of Clinical Oncology|2020Cited by 2